BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

SAS Launches Clinical Acceleration to Modernise Clinical Trial Analytics and Speed Regulatory Submissions

Powered by the data and AI capabilities of SAS Viya, the life sciences solution streamlines drug development to deliver new therapies to patients faster&nb...

November 17, 2025 | News

Volta Labs Expands Callisto Automation Through Strategic Partnership with New England Biolabs

Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned provider of life science reagents,&nb...

November 17, 2025 | News

BostonGene and Kyoto University Launch AI Collaboration to Advance Precision Treatment for Esophageal Cancer

-BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto University, a research institution known for its...

November 14, 2025 | News

Strategic Transaction Positions Crown Bioscience for Global Expansion in Translational Oncology

Strategic Transaction Positions Crown Bioscience for Accelerated Growth in Translational Oncology JSR Life Sciences, a global leader in life sci...

November 14, 2025 | News

Terumo BCT and Santersus Partner to Advance Breakthrough Apheresis Technology for Sepsis Care

Sepsis is one of the most frequent causes of death worldwide, claiming nearly 11 million lives, accounting for 20% of all global deaths and...

November 13, 2025 | News

Thermo Fisher Wins 510(k) Nod for EXENT System to Advance Myeloma Diagnosis

First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support ...

November 13, 2025 | News

MGI Tech, SAMRC and DSTI Launch Africa’s First DNBSEQ-T7 Sequencer and 110K Human Genome Program in South Africa

MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced two historic milestones...

November 12, 2025 | News

SOPHiA GENETICS and Element Biosciences Partner to Merge Sequencing and AI Analytics for Precision Medicine

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pac...

November 12, 2025 | News

Mabwell Secures NMPA Approval to Begin Phase II Trial of First-in-Class Anti-IL-11 Antibody for Pathological Scarring

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its novel anti‑IL‑11 monoclonal antibody...

November 12, 2025 | News

Waters Launches Empower-Integrated Charged Aerosol Detector to Enhance LC-CAD Accuracy and Reliability

Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography ...

November 12, 2025 | News

Simcere Advances Treg-Selective IL-2 Mutant SIM0278 into Phase II Trial for Moderate-to-Severe Atopic Dermatitis

Simcere Pharmaceutical Group (2096.HK) announced that its regulatory T cells (Treg) -preferential IL-2 mutant Fc fusion protein (IL-2 mu-Fc), SIM0278,...

November 11, 2025 | News

Muna Therapeutics Doses First Subjects in Phase 1 Trial of TREM2 Agonist MNA-001 for Alzheimer’s Disease

MNA-001 has best-in-class potential based on preclinical data demonstrating ability to significantly reduce neurotoxic amyloid burden and reprogram microgl...

November 11, 2025 | News

Eli Lilly Partners with SanegeneBio to Advance RNAi Therapies for Metabolic Diseases

-Companies will collaborate on RNAi research for metabolic disease targets SanegeneBio, a clinical-stage biotechnology company developing innov...

November 10, 2025 | News

Eyexora Establishes Co-Headquarters in Singapore to Drive Global Ophthalmic Innovation

-Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, announced the establishment of its co-he...

November 07, 2025 | News

Stay Connected